Investor Class Certified On Claims Pfizer Masked Drug Risks
A New York federal judge on Thursday certified a class of Pfizer Inc. investors accusing the pharmaceutical giant of securities fraud for allegedly concealing studies showing the heart attack risks linked...To view the full article, register now.
Already a subscriber? Click here to view full article